Mylan receives DCGI approval in India for TB drug, Pretomanid EP News Bureau Jul 22, 2020 Pretomanid is only the third new anti-tuberculosis (TB) drug developed specifically for drug-resistant forms of the disease to be…
Biocon presents key Insights into clinical study that enabled DCGI approval of Itolizumab EP News Bureau Jul 14, 2020 A multi-centric, open label, two-arm randomized pivotal clinical trial was conducted in 30 eligible patients at four hospitals…
